<!-- Anki Cards -->
# Sleep Hygeine <!-- tag:sleep-hygiene;id:83737fc0-6123-4404-b669-74545e369519;status:incomplete -->
# Management Pathways for Insomnia <!-- id:71781a9d-e38d-4920-bcc0-43678c53f1da;status:incomplete -->
# Eating Disorders Inpatient Criteria <!-- id:3bde9c2f-16d7-4f83-9f86-e562a82e391d;status:incomplete -->
# Perinatal Psychoeducation <!-- id:1b8aa2e9-9a46-4f9e-89dc-a949b3b4eb25;status:incomplete -->
# Clozapine Psychoeducation <!-- id:60254732-00c2-4eed-a66b-e5a8d4322cff;status:incomplete -->
# ECT Psychoeducation <!-- id:9e20fdbc-41a2-472d-b62f-f5f09569c5d3;status:incomplete -->
# General Education Structure <!-- id:71d12949-a9c4-46b7-837a-b8b81e23ad88;status:incomplete -->
# Consultation-Liaison Reminders <!-- id:3595a6ff-b0f3-4e62-b3ba-c0175d6fb0bf;status:incomplete -->
- Clarify expectations of team
- Feedback to team
# Tourette's Disease Management <!-- id:e1cb3ec5-3cfa-4a73-ac87-2b6fbffc4b1f;status:incomplete -->
---
# General Psychiatry <!-- tag:general-psych;id:a825eeb1-39e6-4b9e-a62c-6e9a1d84d328;status:incomplete -->
## Acute Behavioural Disturbance <!-- tag:sedation;id:b02c2ec4-debf-43e7-bc47-60181d9af79d -->
### Child and Adolescent <!-- id:347280ed-c740-49c5-88f9-014f4b15b151;status:incomplete -->
### Adult <!-- id:3b58e926-58ce-43d6-8a60-3bcb38f7ddca;status:incomplete -->
### Older People <!-- id:fb7df916-f7bc-4f56-836d-f50243e20121 -->
- Exclude delirium and BPSD: treat underlying cause
- Orals
  - Lorazepam 0.5-1mg PO q30mins (max 3mg)
  - Diazepam 2.5-5mg PO q30mins (max 30mg)
  - Preference for lorazepam over diazepam due to shorter action and less metabolites
  - Olanzapine 5-10mg (max 10mg)
  - Risperidone 0.5-1mg (max 2mg)
  - Preference for benzodiazepines as sedatives due to lower dosages required and safer adverse effects compared to antipsychotics
- IMs
  - Olanzapine 2.5mg IM (max 7.5mg)
## Emergencies <!-- tag:emergency;id:ae1640a8-aa87-40e9-a32e-afdc365fa90a;status:incomplete -->
### Neuroleptic Malignant Syndrome <!-- tag:nms;id:c5ea3808-f156-4184-8ac7-a360bdf7178b;status:incomplete -->
### Serotonin Syndrome <!-- tag:serotonin-syndrome;id:80d0c05b-7741-43a8-8cfa-98d82179659c -->
#### Assessment <!-- id:0f6e6566-fcf3-4e2b-8998-4dfc52ead50a -->
- Hx
  - Onset within 24 hrs following commencement or uptitration of serotonergic agent
- Hunter criteria requires serotinergic agent AND
  - Spontaneous clonus
  - (Inducible or ocular clonus) + ((agitation or diaphoresis) or (hypertonia + febrile))
  - Tremor + hyperreflexia
#### Management <!-- id:46626e8a-1641-4d02-b736-5ff4ab206954 -->
- Medical emergency
- Escalation 
### MAOI and Hypertensive Crisis <!-- tag:hypertensive-crisis;id:dd9bec80-00ab-457a-82d9-5455fe8c998f;status:incomplete -->
### Lithium Toxicity <!-- tag:lithium-toxicity;id:a75e3cab-c833-4fd4-8d73-abb7bbe2c455;status:incomplete -->
## Catatonia <!-- tag:catatonia;id:68e202a1-bb2f-4507-982d-5aad4e6404ec -->
### Assessment <!-- id:802ddc59-a9ed-4554-936a-bd0c14860692 -->
- Bush-Francis Catatonia Rating Scale
  - Observe: excitement or stupor, mutism, staring, posturing, grimacing, stereotypy, mannerisms, verbigeration, withdrawal
  - Elicit: echopraxia/echolalia, rigidity, negativism, waxy flexibility, mitmachen, mitgehen, ambitendency
- Concerns: physical health complications (dehydration, VTE, pneumonia)
### Management <!-- id:14696599-305a-4661-8484-fb234cb10d89;status:incomplete -->
- Requires hospitalisation
- Treat underlying cause
- Biological therapy
  - Benzodiazepines ie. lorazepam 2mg, then 3 hrs later. Increase to 8-24mg/day if nil response.
    - Gold standard for affective or organic catatonia
  - ECT
## Eating Disorders <!-- tag:eating-disorders;id:33bdbbbe-885c-4e68-a8b4-8c600715f0f0 -->
### Criteria for Inpatient Management <!-- id:135ed5e3-e1f7-456c-b420-371353cdf01c -->
- Vitals
  - Tachycardia + postural
  - SBP + postural drop
  - Temperature
  - BMI
- Bloods: FBC, LFT, EUC, CMP, glucose
  - Potassium
  - Sodium
  - Glucose
  - Phosphate
  - Magnesium
- ECG
- Psychiatric risks: suicidality, self-harm
- Failure of community management
```
- Vitals
- Ix: bloods, ECG
- Psychiatric risks
```
# Child and Adolescent Psychiatry <!-- tag:child-psych;id:b8c26669-b03e-4758-a7bf-8a3108fd0bcf -->
## Tourette's Disease <!-- tag:tourettes;id:fd4eb78c-5c6a-4421-97b4-d62de6df1db6;status:incomplete -->
### Management <!-- id:b204577e-15f4-4383-b9ff-c6625ef9c3ae -->
- Pharmacotherapy
  - (1) Commence clonidine 50mcg once daily
  - (2) Trial aripiprazole, risperidone or haloperidol
- Psychosocial
  - Cognitive behavioural interventions for tics with **habit reversal training**
  - CBT with **exposure-response prevention**
# Addiction Psychiatry <!-- tag:addiction;id:bc7a05ad-d353-4f85-9638-abcb9b6188b5 -->
## General Structure <!-- id:74e46e68-cfce-4f9b-91de-9007c490c971 -->
- Detoxification
- Rehabilitation
- Relapse prevention
## Alcohol Use Disorder <!-- tag:alcohol-use-disorder;id:3834dfc0-657c-4519-8ca5-a8ff42f2b996 -->
### Management of Alcohol Withdrawal <!-- id:d0ce1e09-b96e-4e93-84d7-fcf101c7187b -->
- Acute ie. withdrawal
  - Thiamine replacement
  - Commencement of alcohol withdrawal scale
  - Benzodiazepine management
    - Consider tapering from 10mg QID + PRN
  - Hydration
### Principles of Brief Intervention <!-- id:4150867c-fc35-47a7-835b-826ab5793a7a;status:incomplete -->
- Brief interventions eg. FLAGS
  - Feedback
### Management of Alcohol Dependence <!-- id:39f7d967-aa86-4ab3-84d2-687d6a9fc510 -->
- Pharmacotherapy
  - Should be reviewed following a lapse, however continue for greater than 6 months if effective
  - Naltrexone
    - Dosing: commence three days after last drink, 25mg for two days, then 50mg daily
  - Acamprosate
    - Dosing: commence three days after last drink, 666mg TDS
  - Disulfiram
    - Dosing: commence 7 days after alcohol withdrawawl and 48 hrs after last drink, 200mg daily
  - Address psychiatric comorbidities eg. anxiety
  - Address physical complications
- Psychological
  - Motivational interviewing
  - CBT approaches
  - Relapse prevention strategies
- Social
  - Self-help programs eg. AA or Smart Recovery
  - Residential rehabilitation
    - 1-12 month programs requiring structured social supports
```
- Bio: naltrexone, acamprosate, disulfiram. Manage psychiatry comorbidity and physical complications.
- Psycho: motivational interviewing, CBT
- Social: self-help, residential rehab
```
[Quick Reference Guide to the Treatment of Alcohol Problems](https://www.health.gov.au/sites/default/files/quick-reference-guide-to-the-treatment-of-alcohol-problems.pdf)
# Psychogeriatrics <!-- tag:psychogeriatrics;id:ff95a940-aed5-49d6-96a8-770a0b7d11d3 -->
## Very-Late Onset Schizophrenia-Like Psychosis <!-- tag:very-late-onset-schizophrenia-like-psychosis;id:3f3e7127-9d64-4b28-aea1-f0b33dd81b24 -->
### Overview <!-- id:4143c9cf-8a6d-4079-a232-08afcc043807;status:incomplete -->
- **Definition**: onset after 60 or 65
# Perinatal Psychiatry <!-- tag:perinatal;id:f7eabf7b-e83f-4b92-8da0-5e91c7159c13 -->
## Postpartum Psychosis <!-- id:0f326e56-768c-4ebc-8f2b-02e631496191;status:incomplete -->
## Principles in Prescribing <!-- id:860c6e1d-9eb0-4520-a323-7aa1092c9df0;status:incomplete -->
- Consider preconception, perinatal and breastfeeding stages
## Antidepressant Usage <!-- id:69aac442-691a-4793-932f-b7d785644aa6;status:incomplete -->
## Antipsychotic Usage <!-- id:669c28c7-c2f2-4e2f-a23f-ffa6289630b8;status:incomplete -->
## Mood Stabiliser Usage <!-- id:a29062af-c679-4ede-b51b-df0684f36416;status:incomplete -->
---
